Related Experiment Video
Updated: Jul 15, 2026
09:33
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Next steps in Alzheimer's disease research: interaction between epidemiology and basic science.
1National Institute on Aging, Bethesda, MD 20892, USA. launerl@nia.nih.gov
Current Alzheimer Research
|April 14, 2007
Summary
Epidemiologic studies reveal key insights into Alzheimer's disease (AD) etiology, prognosis, and prevention. Findings from these studies can guide basic research toward clinical and public health applications.
Area of Science:
- Epidemiology
- Neuroscience
- Public Health
Background:
- Epidemiologic studies offer crucial insights into Alzheimer's disease (AD).
- These studies explore AD etiology, prognosis, prevention, and treatment.
- They also examine sub-clinical cognitive and structural brain changes.
Purpose of the Study:
- To review findings from epidemiologic studies on AD risk factors and natural history.
- To discuss how these findings can inform basic research strategies.
- To facilitate the translation of research from the lab to clinical practice and public health.
Main Methods:
- Review of existing epidemiologic studies on Alzheimer's disease.
- Analysis of identified risk factors and disease natural history.
- Discussion of translational research pathways.
Main Results:
- Epidemiologic data provides a foundation for understanding AD.
- Identified risk factors and natural history patterns are crucial.
- Translational strategies can bridge basic science and clinical application.
Conclusions:
- Epidemiologic research is vital for advancing Alzheimer's disease understanding.
- Findings can guide the development of effective prevention and treatment strategies.
- Translating research is essential for public health impact.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...